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Avian-specific toll like receptor 15 (TLR15) is functionally equivalent to a group of TLR2 family proteins that the
mammalian innate immune system utilizes to recognize a broad spectrum of microbe-associated molecular
patterns, including bacterial lipoproteins. In this study we examined the role of chicken TLR2 family members in the
innate immune response to the avian pathogenic bacterium, Mycoplasma synoviae. We found that Mycoplasma
synoviae, and specifically the N-terminal diacylated lipopeptide (MDLP) representing the amino-terminal portion of
its mature haemagglutinin protein, significantly induces the expression of TLR15, but not TLR1 and TLR2 in chicken
macrophages and chondrocytes. TLR15 activation is specific and depends on diacylation of the lipopeptide.
Activation of TLR15 after stimulation with Mycoplasma synoviae and MDLP triggers an increase in the expression of
transcription factor nuclear factor kappa B and nitric oxide production. Moreover, transfection of avian macrophage
cells with small interfering RNA reduces the expression of TLR15 after stimulation with MDLP. This leads to
decreased activation of the innate immune response, as measured by nitric oxide production. Additionally,
pretreatment of cells with neutralizing anti-TLR15 antibody results in a notable attenuation of MDLP-driven release
of nitric oxide. This positive correlation may constitute a mechanism for stimulating the innate immune response
against avian mycoplasmas in chicken cells via TLR15.Introduction
Mycoplasmas are the smallest self-replicating organisms,
and are distinguished from other bacteria by their small
size and total lack of a cell wall. As obligate parasites
they usually exhibit strict host and tissue specificity.
Mycoplasmas have been shown to interact with the
host’s immune system on many levels, which includes
modulating the host immune system and stimulating an
inflammatory response. These abilities enable mycoplas-
mas to establish a chronic, persistent infection (reviewed
in [1]). In poultry the most pathogenic species are Myco-
plasma synoviae and Mycoplasma gallisepticum. Myco-
plasma synoviae most frequently colonizes the upper
respiratory tract, causing subclinical infections, although
this condition can also lead to the development of sys-
temic infection and/or infectious synovitis in chickens
and turkeys [2,3]. In the absence of a cell wall, the* Correspondence: mojca.narat@bf.uni-lj.si
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reproduction in any medium, provided the ormajority of the mycoplasma surface antigens are lipopro-
teins. In the avian pathogens Mycoplasma gallisepticum
and Mycoplasma synoviae an abundantly expressed
variable lipoprotein haemagglutinin (VlhA) is believed
to play a major role in pathogenesis of the disease by
mediating adherence and immune evasion [4]. VlhA is
post-translationaly cleaved into 2 proteins, the amino
terminal lipoprotein portion MSPB and the more anti-
genically variable C terminal haemagglutinin MSPA. In
phenotypically distinct Mycoplasma synoviae popula-
tions truncated forms of MSPB (tMSPB) also occur
[3,5,6]. Both MSPB and tMSPB contain an amino ter-
minal proline rich region [5], which has been shown to
induce strong local and systemic antibody responses in
infectious synovitis [3] and the production of proin-
flammatory cytokines and other effector molecules [7],
although the mechanisms underlying this response are
still not clear. Other Mycoplasma lipoproteins and
lipopeptides have also been found to be subject to
similar post-translational modifications. One of thesetd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Mycoplasma fermentas, which is derived from a 43 kDa
surface lipoprotein that is post-translationally cleaved
into the mature 14-residue long N-terminal lipopeptide
MALP-2 [8].
Bacterial lipoproteins, including mycoplasmal lipopro-
teins, belong to a group of pathogen associated molecular
patterns (PAMPs) which interact with Toll like receptors
(TLRs) present on host cells [9]. In humans, TLR1, TLR2
and TLR6 are implicated in the recognition of bacterial li-
poproteins, where TLR2 dimerizes with either TLR1 or
TLR6 to enhance the recognition of lipoproteins and elicit
the cellular cytokine response through the activation of nu-
clear factor kappa B (NF-κB ) and the mitogen activated
protein kinase signaling cascade [10].
In birds, 10 avian TLRs have been described so far, of
which TLR2a, TLR2b, TLR3, TLR4, TLR5, and TLR7 are
orthologs to those found in humans. Additionally, avian
TLR21, which is absent from mammalian genome, is the
functional homologue of mammalian TLR9, recognizing
CpG DNA. Besides TLR2a and TLR2b, members of the
avian TLR2 group also include two TLR1-like proteins
(TLR1La and TLR1Lb), and TLR15, which appears to be
unique to avian and reptile species [11]. Orthologs of mam-
malian TLR6 and TLR10 have not been found in birds
(reviewed in [12]). Several studies report that both types of
chTLR1L can interact with both types of chTLR2 in differ-
ent combinations in response to bacterial lipoproteins, al-
though the findings of these studies are somewhat
contradictory [13-15]. TLR15 has so far been identified only
in avian and reptile species [11]. Its induction was first ob-
served in the cecum of chickens infected with Salmonella
enterica [16]. Later studies have also reported the induction
of chTLR15 after stimulation of chicken fibroblasts and het-
erophils by heat-killed Gram-negative and Gram-positive
bacteria, but not by any of the other tested TLR agonist
[17-20]. A more recent study reported the induction of
TLR15 mRNA expression after stimulation with CpG-
oligonucleotide (CpG-ODN), tripalmitoylated lipopeptide
(PAM3CSK4) and lipopolysaccharide (LPS) [21], whereas
another study suggested a novel mechanism of activation,
where TLR15 is activated through its cleavage by microbial
proteases [22]. A third recent study showed that yeast ly-
sates can induce the TLR15-dependent activation of NF-κB
expression, however, the exact agonist was not identified
[11]. Nevertheless, the fact that TLR15 induction appears
to be unique to the avian species and is molecularly distinct
from other known TLRs, suggests a specific and unique
role in defense against avian pathogens [18].
In this study we report a novel ligand for TLR15, a
diacylated lipopeptide derived from Mycoplasma
synoviae, a common chicken pathogen. We used a syn-
thetic diacylated lipopetide (MDLP) based on the N-
terminal sequence of MSPB, and its diacyl modificationwas chosen by anology to other Mycoplasma-derived
lipopeptides (eg. MALP-2, FSL-1). Its non acylated pep-
tide analog (NAP) was also synthesized. We found that
MDLP was capable of inducing TLR15 expression, which
led to NF-κB activation and nitric oxide production.Materials and methods
Reagents and chemicals
Unless otherwise noted, reagents and chemicals were
purchased from Sigma–Aldrich Corp., St. Louis, USA.Mycoplasma synoviae culture
Mycoplasma synoviae strains WVU 1853 and ULB 01/
P4 were grown at 37 °C on modified Frey’s medium
containing 12% porcine serum (Life Technologies Inc.,
Gaithersburg, USA) and 0.1 g of NAD per liter of broth
medium (Merck & Co. Inc., Whitehouse Station, USA),
but without addition of thallium acetate [23].MSPB lipoprotein isolation and lipopetide / peptide
determination
MSPB lipoprotein was isolated from Mycoplasma synoviae
strain ULB 01/P4 as previously described [7]. The amino
acid sequence of the N-terminal region of MSPB proteins
of type strain WVU1853 and strain ULB 01/P4 were pre-
dicted previously [5] from the 5′-end of the vlhA gene se-
quence. The proposed N-terminal amino acid sequence
(CGDQTPAPEPTPGNPNTDNPQNPN) was the same in
both strains. Based on this sequence, the 14 amino acid
NAP peptide (CGDQTPAPEPTPGN) was synthesized, as
well as the corresponding lipopeptide, MDLP, containing
an S-(2,3-bispalmitoyloxypropyl) N-terminal modification
(Pam2CGDQTPAPEPTPGN) (both EMC microcollections
GmbH, Tuebingen, Germany), which mimics the putative
diacyl lipid moiety found in mycoplasma lipoproteins [8].Cell cultures
The chicken macrophage cell line HD11 was cultured in
RPMI medium, supplemented with 8% fetal bovine serum
(FBS) and 2% chicken serum, at 37 °C in a 5% CO2 atmos-
phere. Monocyte-derived macrophages (MDM) were pre-
pared by Histopaque®-1077 density gradient centrifugation
of chicken blood as described previously [7,24] and plated
in RPMI 1640 medium, supplemented with 10% FBS
(Hyclone, USA), 100 U/mL penicillin, and 100 U/mL
streptomycin, at 41 °C in a 5% CO2 atmosphere.
Primary chicken chondrocytes (CCH) were isolated as
previously described [25]. CCH were cultivated up to six
passages in DMEM medium supplemented with 7.5%
FBS and 2.5% chicken serum. Cells were incubated at
37 °C in a 5% CO2 atmosphere.
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Pam2CGDQTPAPEPTPGN lipopeptide (MDLP) and
CGDQTPAPEPTPGN peptide (NAP)
The number of Mycoplasma synoviae cells per macro-
phage (HD11) was adjusted using the colony forming
units (CFU) technique, as previously described [24].
HD11 cells were exposed to bacteria by replacing their
growth medium with medium containing bacteria at a
multiplicity of approximately 100 viable Mycoplasma
synoviae cells per macrophage. HD11, CCH and MDM
cells were exposed to 1 μM of MDLP or 1 μM NAP.
Non-exposed cells were used as negative controls. Cell
cultures exposed to different agents were incubated at
37 °C (for HD11 and CCH) or 41 °C (for MDM) and 5%
CO2 before harvesting cells for RNA. At 1, 6, or 24 h of
exposure, growth medium was aspirated from plates,
RLT lysis buffer (Qiagen Corp., Valencia, USA) was
added and cells were harvested with a rubber policeman.
Quantitative real-time RT-PCR
To confirm and validate gene expression changes quan-
titative real-time RT-PCR (RT-qPCR) was performed on:
chTLR15, chTLR1, chTLR2, iNOS and NF-κB using
GAPDH as a housekeeping control gene (Table 1). RT-
qPCR primers were designed using PrimerQuestSM (In-
tegrated DNA Technologies, Leuven, Belgium) and
checked for specificity in silico with PrimerBlast (NCBI).
RNA was isolated from cells using the RNAeasy mini kit
following on- column DNase-I digestion in accordance
with the manufacturer’s protocol (Qiagen). cDNA was
reverse transcribed using the High-Capacity cDNA Re-
verse Transcription Kit (Applied Biosystems, Foster City,
USA). RT-qPCR assays were performed using the 2×
FastStart Universal SYBR Green Master Mix (Rox)
(Roche Diagnostics GmbH, Mannheim, Germany).
Quantitative PCR was performed for each sample in
triplicate on an Mx3000p QPCR System (Agilent Tech-
nologies – Stratagene, Santa Clara, USA). The three-step
amplification procedure was performed in a 20 μL reac-
tion volume containing 300 nM of each primer and
150 pg of cDNA. Reaction conditions were set to 10 min
at 95 °C (first segment, one cycle), 15 s at 95 °C andTable 1 Oligonucleotides used as primers in RT-qPCR analysis








NF-κB NM_205134.1 AGGACTT1 min at the Tm of the specific primer pair (second
segment, 40 cycles) followed by one cycle with 15 s at
95 °C, 30 s at the designated Tm and 15 s at 95 °C (dis-
sociation curve segment). Data were analyzed using
MxPro 4.0 Software (Agilent Technologies). Gene ex-
pression values of non-infected or non-treated cells were
used for gene expression calibration. Appropriate con-
trols (no template and no reverse transcription control)
were also performed in each run. At least three inde-
pendent experiments were performed to collect RNA for
RT-qPCR. Relative gene expression was assayed in each
experiment and experimental condition separately. Nor-
malized relative quantities were calculated using the effi-
ciency corrected 2-(ΔΔCt) method [26]. The effect of
intra-assay variation on the statistical significance of the
results was reduced by log transformation of normalized
relative quantities, mean centering and autoscaling by
the method of Willems et al. [27].
Western blotting
1 × 106 HD11 cells were cultured in RPMI containing
8% FBS and 2% chicken serum overnight and were then
stimulated with 1 μM MDLP or NAP for 24 h. Cell
lysates were prepared in RIPA buffer. Protein content
was determined and equal amounts of lysates were frac-
tionated by 10% SDS-PAGE and electrotransferred to
polyvinylidene difluoride membranes. Rabbit polyclonal
anti-TLR15 antibody (Imgenex, San Diego, USA) and
anti -actin 2Q1055 antibody (Abcam, Cambridge, UK)
were used for the detection of proteins. Detection was
by an enhanced chemiluminescence system (Amersham,
Freiburg, Germany).
Nitric oxide assay
Nitric oxide (NO), induced in HD11 cells by DLP, was
estimated, with some modifications, as previously de-
scribed [7]. Briefly, HD11 cells were seeded into 24-well
plates (2 × 105 cells / well) and NAP or MDLP was
added to a final concentration of 0.5, 1 or 1.5 μM. As a
positive control HD11 cells were incubated in the pres-
ence of 0.1 μg/mL E. coli O127:B8 LPS. Cell culture su-
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after 24 h. Quantification of nitric oxide was performed
using the Griess Reagent System (Promega GmbH,
Mannheim, Germany), according to the manufacturer’s
instructions.
RNA silencing
Silencing of TLR15 was performed using the Screening
DsiRNA TriFECTa Kit (cat.# GGC.RNAI.N001037835.12,
Integrated DNA Technologies). A universal negative con-
trol siRNA (NC siRNA) not homologous to any known
transcript in the vertebrate transcriptome, was used to
normalize relative gene inhibition of the target gene. A
positive control siRNA against HPRT-1 was used to assess
transfection and knockdown efficiency. Twenty-four h be-
fore transfection, 8 × 104 HD11 cells / well were seeded
onto a 24-well plate to reach 40-50% confluence. These
cells were transfected with a cocktail of three TLR15
siRNAs (150 nM total) or a nonsense negative control (NC
siRNA), using the chemical transfection reagent X-treme
GENE siRNA Transfection reagent (Roche). Transfection
was performed according to the manufacturer’s instruc-
tions. Briefly, siRNAs were diluted in 50 μL Opti-MEM
medium and mixed gently. Four μL of X-tremeGENE was
diluted in 50 μL Opti-MEM medium and combined with
the diluted RNAi duplex, incubated for 20 min at room
temperature, then added to each well containing cells to
give a final volume of 500 μL and a final siRNA concentra-
tion of 150 nM. The conditions for siRNA transfection
were optimized by adjusting different siRNA concentrations
(10, 50, and 150 nM) and different transfection methods
(reverse and forward) using Tye 563™ Fluorescent Control
(Integrated DNA Technologies). Transfection efficiency
was evaluated under a fluorescent microscope. Eight hours
after transfection, HD11 cells were treated with 1 μM
MDLP or NAP for 12 h, and RNA isolated from cells or
NO was measured in the supernatant as described above.
Antibody neutralization assay
HD11 cells (5 × 104 cells / well) were seeded onto 96-
well culture plates and pre-treated with 2.5 μL of rabbit
polyclonal anti-TLR15 antibodies (Imgenex), 2.5 μL of
normal rabbit serum (1:1 in glycerol) or PBS for 1 h at
37 °C in 5% CO2. Following the 1 h incubation, 1 μM
MDLP or NAP were applied in the continuing presence
of neutralizing antibodies, and the cells were further in-
cubated overnight in the same conditions. NO from cell
supernatants was determined as described above.
Statistical analysis
Statistical analysis was performed for selected experi-
ments to determine the confidence limit at which two
measurements were statistically different. A Student t-
test (p < 0.05) was applied to each dataset in SigmaPlotprogram, and p-values were obtained and are reported
in the figure legends.
Results
Expression of TLR15, TLR1 and TLR2 genes after infection
of HD11 cells with Mycoplasma synoviae
We first sought to determine which chicken TLR2 fam-
ily members are involved in the immune response to
Mycoplasma synoviae infection of macrophages. There-
fore, we analyzed the expression of TLR15, TLR1 and
TLR2 genes after infection of HD11 macrophages with
live Mycoplasma synoviae for 1, 6 or 24 h. For the ana-
lysis of TLR1 and TLR2 mRNA expression we used
primers that recognized both forms of each chTLR re-
ceptors. As shown in Figure 1A, infection of HD11 cells
with Mycoplasma synoviae significantly induces the ex-
pression of TLR15 (approximately 8-fold, p < 0.001) after
1 h and 6 h, whereas after 24 h the expression of TLR15
was not up-regulated compared with non-infected cells.
Interestingly, the expression of TLR1 and TLR2 was not
up-regulated; moreover, they were significantly down-
regulated after 6 h and 24 h (p < 0.001) (Figure 1A).
It was previously shown that the N-terminal lipoprotein
fraction of VlhA is responsible for the induction of a strong
immune response [7]. Based on the N-terminal sequence of
the MSPB protein, and by analogy to MALP-2 and FSL-1,
we synthesized the Pam2CGDQTPAPEPTPGN lipopeptide,
termed MDLP, and its non-acylated peptide analog, NAP.
We analyzed the transcription levels of the TLR15, TLR1
and TLR2 genes in HD11 cells after treating them with ei-
ther 1 μM MDLP or NAP for 1 h, 6 h or 24 h. As shown in
Figure 1B MDLP significantly induces the expression of
TLR15 compared with non-treated cells and NAP-treated
cells. The expression of TLR15 was highest after 1 h of ex-
posure (13-fold compared with non-treated cells,
p < 0.001). The expression of TLR15 was not up-regulated
when the cells were treated with the non-modified peptide
(Figure 1B, NAP). The expression of TLR15 was still up-
regulated after 6 h and 24 h (6.5-fold and 5-fold, respect-
ively, p < 0.001). Interestingly, as with the Mycoplasma
synoviae infection experiment, the mRNA expressions of
TLR1 and TLR2 were significantly down-regulated after the
treatment of the cells with MDLP (p < 0.01), whereas when
treated with NAP, the expression remained the same com-
pared to non-treated cells (Figure 1B, TLR1 and TLR2,
respectively).
Since HD11 cells are a virally transformed macrophage
cell line, we wanted to confirm that this cell line is a suit-
able model for our experiments by analyzing the expression
of TLR15, TLR1 and TLR2 genes in primary macrophages.
Therefore, we isolated monocyte derived macrophages
from chicken blood and treated them with 1 μM of MDLP
or NAP for 1 h, 6 h or 24 h. At each time point expression
of the TLR15, TLR1 and TLR2 genes was analyzed. As
Figure 1 Mycoplasma synoviae and its diacylated lipopeptide induce expression of TLR15 in chicken macrophages. A) Expression of
TLR15, TLR1 and TLR2 mRNA after infection of HD11 cells with Mycoplasma synoviae. HD11 cells were infected with live Mycoplasma synoviae (MS)
for 1 h, 6 h or 24 h and mRNA expression was analyzed by RT-qPCR. NC represents non-infected cells. Bars show mean ± S.E. (n = 4); ***, p < 0.001
compared to non-infected cells. B) Expression of TLR15, TLR1 and TLR2 mRNA after treatment of HD11 cells with diacylated lipopeptide or its non-
acylated analog. HD11 cells were treated with 1 μM non-acylated peptide (NAP) or diacylated lipopeptide (MDLP) for 1 h, 6 h or 24 h and mRNA
expression was analyzed by RT-qPCR. NC represents non-treated cells. Bars show mean ± S.E. (n = 4); **, p < 0.01 and ***, p < 0.001 compared to
NAP-treated cells at each time point for selected gene. C) Expression of TLR15, TLR1 and TLR2 mRNA after treatment of MDM cells with diacylated
lipopeptide or its non-acylated analog. MDM cells were treated with 1 μM non-acylated peptide (NAP) or diacylated lipopeptide (MDLP) for 1 h,
6 h or 24 h and mRNA expression was analyzed by RT-qPCR. NC represents non-treated cells. Bars show mean ± S.E. (n = 3); *, p < 0.05 and **,
p < 0.01 compared to NAP-treated cells at each time point for selected gene. D) Expression levels of TLR15 and β-actin, as determined by
Western blotting. HD11 cells were treated with NAP or MDLP for 24 h and TLR15 protein levels were determined. Levels of endogenous β-actin
were determined by Western blotting to validate input for each sample.
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sion of TLR15 compared with non-treated cells and NAP-
treated cells. The expression of TLR15 was highest after 1 h
of exposure (4.6-fold compared with non-treated cells,
p = 0.003). The expression of TLR15 was not up-regulated
when the cells were treated with the non-modified peptide
(Figure 1C, NAP). At longer treatment times (6 h and 24 h)
the expression of TLR15 was still induced although the
level was not statistically significant (2.6-fold and 1.5-fold,
p = 0.025 and p = 0.139, respectively).To confirm that the expression of TLR15 was induced
not only at the mRNA level, but also at the protein level,
we performed a western blot analysis in HD11 cells after
24 h of exposure to MDLP or NAP. Changes in protein
levels were consistent with the mRNA data, showing
that NAP did not affect the expression of TLR15 pro-
tein, whereas treatment with MDLP induced up-
regulation of TLR15 protein expression (Figure 1D).
Mycoplasma synoviae has been shown to interact with
non-immune cells, and is often isolated from the joints
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vestigate if Mycoplasma synoviae can modify the expres-
sion of chicken TLR2-family genes in non-immune cells,
we infected primary chicken chondrocyte cells (CCH)
with Mycoplasma synoviae for 1 h, 6 h and 24 h, and an-
alyzed the expression of TLR15, TLR1 and TLR2 genes.
In contrast to the response in the immune cells, the ex-
pression of TLR15 was the highest after 24 h of infection
(11-fold, p < 0.001), whereas TLR1 and TLR2 expression
remained unchanged or was even slightly down-
regulated, correlating to the results observed in chicken
macrophages (Figure 2A). We found similar results
when we treated CCH cells with MDLP or NAP. MDLP
induced TLR15 expression in CCH after 1 h (Figure 2B,
6-fold, p = 0.005), and the expression of the TLR15 was
further increased after 6 h and 24 h (Figure 2B, 12-fold
and 17-fold, p < 0.001 and p = 0.002, respectively). NAP
did not change the expression of any of the analyzed
TLRs compared with non-infected cells (Figure 2B).
Increased TLR15 expression is associated with increased
NF-κB, iNOS message and nitric oxide production
To further investigate the mechanism of the TLR15 me-
diated innate immune response, we measured NF-κB
mRNA expression following infection of HD11 cells with
viable Mycoplasma synoviae or treatment with MDLP
compared to non-infected or NAP-treated cells as con-
trols. Both viable Mycoplasma synoviae cells and MDLPFigure 2 Mycoplasma synoviae and its diacylated lipopeptide induce
Expression of TLR15, TLR1 and TLR2 mRNA after infection of cells with Myco
Mycoplasma synoviae (MS) for 1 h, 6 h or 24 h and mRNA expression was a
mean ± S.E. (n = 4); ***, p < 0.001 compared to non-infected cells. B) Expres
diacylated lipopeptide or its non-acylated analog. Primary chicken chondro
diacylated lipopeptide (MDLP) for 1 h, 6 h or 24 h and mRNA expression w
mean ± S.E. (n = 4); **, p < 0.01 and ***, p < 0.001 compared to NAP-treatedinduced elevated levels of NF-κB transcripts in HD11
cells after 1 h and 6 h (2.3- and 3.6-fold, p < 0.01 for
Mycoplasma synoviae, and 3- and 3.4-fold, p < 0.001 for
MDLP, respectively), whereas non-stimulated or NAP
stimulated cells did not induce NF-κB transcription
(Figure 3). The expression of NF-κB mRNA was
inhibited after 24 h (Figure 3).
Increased NF-κB mRNA expression also corresponded
to an increased innate immune response, as monitored
by changes in iNOS mRNA level and its associated NO
production as a functional measure of TLR15 activation.
HD11 cells were infected with Mycoplasma synoviae or
treated with 1 μM MDLP or NAP for 1 h, 6 h and 24 h,
and iNOS mRNA levels were measured by RT-qPCR.
The infection of cells with Mycoplasma synoviae or
treatment with MDLP resulted in a significant increase
in iNOS mRNA expression after 6 h and 24 h
(Figure 4A). The treatment of cells with NAP did not in-
duce iNOS expression at any time point (Figure 4A). We
next investigated if elevated iNOS mRNA levels correlate
with the production of NO in HD11 cell culture super-
natants after stimulation of the cells with increasing
amount of MDLP or NAP. LPS was used as a positive
control. As shown in Figure 4B, treatment of cells with
MDLP or LPS indeed resulted in NO production after
6 h and 24 h, whereas NAP did not stimulate NO pro-
duction. In addition, MDLP induced NO at similar levels
compared to LPS (Figure 4B). MDLP was also able toexpression of TLR15 in primary chicken chondrocytes. A)
plasma synoviae. Primary chicken chondrocytes were infected with live
nalyzed by RT-qPCR. NC represents non-infected cells. Bars show
sion of TLR15, TLR1 and TLR2 mRNA after treatment of cells with
cytes were treated with 1 μM non-acylated peptide (NAP) or
as analyzed by RT-qPCR. NC represents non-treated cells. Bars show
cells at each time point for selected gene.
Figure 3 Mycoplasma synoviae and its diacylated lipopeptide
induce transcription of NF-κB in HD11 macrophages. HD11 cells
were infected with Mycoplasma synoviae (MS) or treated with 1 μM
non-acylated peptide (NAP) or diacylated lipopeptide (MDLP) for
1 h, 6 h or 24 h and mRNA expression was analyzed by RT-qPCR.
NC represents non-infected cells. Bars show mean ± S.E. (n = 6); *,
p < 0.05 and ***, p < 0.001 compared to non-treated cells for
Mycoplasma synoviae or NAP-treated cells at each time
point, respectively.
Figure 4 Mycoplasma synoviae derived diacylated lipopeptide induce
iNOS gene after infection of cells with Mycoplasma synoviae or treatment w
synoviae (MS) or treated with 1 μM non-acylated peptide (NAP) or diacylate
analyzed by RT-qPCR. NC represents non-infected cells. Bars show mean ±
synoviae or NAP-treated cells at each time point, respectively. B) MDLP ind
0.5, 1 or 1.5 μM non-acylated peptide (NAP) or diacylated lipopeptide (MDL
assay. NC represents non-treated cells. LPS treated cells were used as posit
MDLP. Bars show mean ± S.E. (n = 4); ***, p < 0.001 compared to non-treate
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leukin 6 (IL-6) (data not shown).MDLP-induced nitric oxide production is mediated via
TLR15
To confirm the role of TLR15 in MDLP-mediated NO
production, we knocked down TLR15 expression in
HD11 cells using siRNA. The expression level of TLR15
diminished following transfection of HD11 cells with
siRNA specific for chicken TLR15. Under stimulated
conditions, cells transfected with TLR15 siRNA
exhibited a decline in TLR15 mRNA expression of 70%
(p < 0.001, NAP) and 80% (p < 0.001, MDLP) of the con-
trol values at 24 h post-transfection in NAP-treated or
MDLP-treated cells, respectively (Figure 5A). The con-
trol transfection with scrambled siRNA (Figure 5A, NC
siRNA) did not affect the expression levels of TLR15.
TLR15 mRNA expression was low in control NC siRNA
cells under unstimulated conditions and significantly in-
creased in response to MDLP stimulation (p < 0.001). The
increase in TLR15 mRNA expression induced by MDLP
was significantly inhibited in TLR15-diminished cells as a
consequence of effective interference of TLR15 mRNA
transcription by TLR15 siRNA (Figure 5A, p < 0.001).
Transfection and knockdown efficiencies were evaluated
by transfection of cells with TYE 563™ (Additional file 1A)
and control HPRT-1 siRNA (Additional file 1B).
The influence of a reduction in TLR15 expression on
iNOS induction by MDLP stimulation was also investigated.s iNOS expression and NO production. A) Expression of the avian
ith diacylated lipopeptide. HD11 cells were infected with Mycoplasma
d lipopeptide (MDLP) for 1 h, 6 h or 24 h and mRNA expression was
S.E. (n = 4); ***, p < 0.001 compared to non-treated cells for Mycoplasma
uces NO production in macrophages. HD11 cells were or treated with
P) for 6 h or 24 h, and production of nitrite was measured by Griess
ive control. Triangles represent increasing concentrations of NAP or
d cells for LPS or NAP-treated cells at concentration, respectively.
Figure 5 Silencing of TLR15 decreases iNOS gene expression and NO production in MDLP stimulated HD11 macrophages. A) Silencing
of TLR15 decreases iNOS gene expression. HD11 cells were transfected with siRNA specific for TLR15 (TLR15 siRNA) or scrambled negative control
siRNA (NC siRNA) for 8 h and then stimulated with NAP or MDLP for additional 12 h. mRNA expression for iNOS and TLR15 was determined by
RT-qPCR. Bars show mean ± S.E. (n = 4); **, p < 0.01 and ***, p < 0.001. B) Silencing of TLR15 decreases MDLP-induced NO production. HD11 cells
were transfected with TLR15 siRNA or NC siRNA for 8 h and then stimulated with NAP or MDLP for additional 12 h. After, production of nitrite
was measured in cell culture supernatants by Griess assay. Bars show mean ± S.E. (n = 4); ** p < 0.01.
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significant increase in iNOS expression (Figure 5A, iNOS,
p < 0.001). As anticipated, iNOS induction by MDLP stimu-
lation was significantly inhibited in TLR15-deficient cells
(p= 0.001, Figure 5A, iNOS). Furthermore, this data was
corroborated by observed changes in NO production. Fol-
lowing treatment with DLP, NO levels in cell supernatants
were markedly increased in NC siRNA cells, but NO pro-
duction was significantly inhibited in TLR15-diminished
cells (p= 0.003, Figure 5B). This data further suggests that
TLR15 may be essential for iNOS induction and NO pro-
duction by MDLP stimulation.
MDLP-induced NO production is inhibited by blocking
TLR15
To further asses the role of TLR15 in MDLP-induced in-
nate immune responses in chicken macrophages, we in-
vestigated the effect of blocking TLR15 with anti-TLR15
antibodies on NO production (Figure 6). Pre-incubation
of HD11 cells with neutralizing rabbit polyclonal anti-
TLR15 antibody for 1 h, followed by stimulation with
MDLP or NAP, resulted in almost complete inhibition of
NO production. Normal rabbit serum showed signifi-
cantly lower inhibitory effect in comparison to TLR15
antiserum (p = 0.001).Discussion
In mammalian cells, lipopeptides mediate an innate im-
mune response through interactions with TLR1, TLR2 and
TLR6. Chickens lack TLR6 but possess two types of TLR1
and two types of TLR2 receptors that are most likely the re-
sult of gene duplication [28,29], and an additional avian
specific receptor, TLR15. Therefore, this study was designed
to address if TLR15 is involved in the recognition of Myco-
plasma synoviae lipoprotein MSPB. We found that this
avian pathogen, and specifically the N-terminal diacylated
lipopeptide portion of MSPB (MDLP), activates the expres-
sion of TLR15 in chicken macrophages and primary
chicken chondrocytes. The activation of TLR15 leads to
NF-κB activation and NO production. The specificity of
this interaction was confirmed by the inhibition of iNOS
expression and NO production through the depletion of
TLR15 by siRNA. Moreover, when cells were pretreated
with neutralizing anti-TLR15 antibody, MDLP-mediated
NO production was inhibited. We conclude that by
interacting with TLR15 MDLP stimulates an innate im-
mune response in chicken cells.
Previous studies by Lavrič et al. showed the induction
of proinflamatory cytokines and chemokines, as well as
iNOS, in Mycoplasma synoviae infected chicken macro-
phages [24]. Moreover, a second study showed that
Figure 6 Preincubation of HD11 macrophages with anti-TLR15
antibody decreases MDLP-stimulated NO response. HD11 cells
were preincubated with rabbit polyclonal anti-TLR15 antibody,
normal rabbit serum (rabbit IgG) or phosphate buffer (PBS) for 1 h
and then stimulated with NAP or MDLP for 24 h. Nitrite
concentration in cell culture supernatants was measured by Griess
assay. PBS-pretreated cells were used as control. Bars show mean ±
S.E. (n = 3); ***, p < 0.001.
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were responsible for a strong immune response in
chicken macrophages with production of NO, IL-6 and
IL-1β [7], similarly to what has been shown for other
mycoplasma lipopeptides, such as MALP-2 and FSL-1
[8,30]. The N-terminal amino acid sequence of WVU
1853 strain tMSPB is CDGQTPAPEXT [7], in which two
acyl chains are bound to a cysteine [8,31]. The study by
Lavrič et al. also suggested that the induction of
proinflamatory cytokines as well as iNOS could be a
functional consequence of TLR pathway induction
through Mycoplasma synoviae PAMPs.
In mammals, mycoplasma lipopeptides MALP-2 and
FSL-1 initiate innate immune response through the TLR2/
TLR6 mediated signaling pathway. However, in chickens,
the signaling pathway involved in Mycoplasma synoviae
mediated immune response has not yet been determined.
We have therefore evaluated the involvement of chicken
TLR2 subfamily members in the Mycoplasma synoviae and
MSPB-derived lipopeptide, MDLP, mediated immune re-
sponse. Our results show that MDLP was able to rapidly in-
duce the expression of TLR15, whereas expression of the
other two chTLR2 family members, TLR1 and TLR2, was
down-regulated in response to MDLP. This result was spe-
cific for the lipid moiety since NAP did not induce any
changes in the expression of chTLR2 family members.In general, the binding of a TLR to its appropriate lig-
and initiates a specific signaling cascade, ultimately
resulting in the activation of transcription factor NF-κB,
and the expression of innate immune response genes,
such as proinflamatory cytokines and iNOS. This path-
way is mostly conserved in avian species [28]. In the
present study, the innate immune response to MDLP in
HD11 cells was monitored by the induction of iNOS
and its associated NO production. We show that stimu-
lation of chicken macrophages with Mycoplasma
synoviae or MDLP leads to the activation of NF-κB and
iNOS, which in turn leads to the production of nitric
oxide. The levels of NF-κB and iNOS expression were
time dependent, with NF-κB peaking at 6 h, followed by
iNOS at 24 h. Participation of TLR15 in MDLP stimula-
tion was corroborated by reducing TLR15 transcription
by RNA silencing. iNOS expression and NO production
were significantly inhibited in TLR15-diminished cells
compared with control NC siRNA cells. Moreover, the
MDLP-induced NO response in macrophages was abro-
gated by blocking antibodies specific for TLR15.
Induction of iNOS, and the resulting increase in NO
production, not only has a positive role in combating in-
fectious disease but also contributes to a number of
autoimmune and inflammatory disorders. Mycoplasma
synoviae has been associated with infectious synovitis in
joints of naturally and experimentally infected chickens
[3,23]. A recent study by Dušanić et al. [32] has shown
that infection of primary chicken chondrocytes with
Mycoplasma synoviae induces NF-κB expression and
NO production. Therefore, we investigated the involve-
ment of the chTLR2 subfamily in the recognition of
Mycoplasma synoviae and its diacylated lipopeptide in
chicken chondrocytes. Our results showed that Myco-
plasma synoviae infection induced expression of TLR15
mRNA in chicken chodrocytes after 24 h. The expres-
sion of TLR1 remained unchanged, whereas the expres-
sion of TLR2 was significantly downregulated. We also
showed upregulation of TLR15 after 6 h and 24 h of
stimulation by MDLP, but not NAP, whereas the ex-
pressions of TLR1 and TLR2 remained unchanged. The
expression of TLR2 has also been shown in human
chondrocytes, where activation of the TLR2 pathway
led to the production of NO, resulting in an inflamma-
tory response [33]. In mice, the expression of TLR2
resulted in experimentally induced arthritis [34]. Taken
together these findings suggest that an innate immune
response, including MDLP-mediated activation of chicken
chondrocytes via the TLR15 pathway, has the potential to
contribute to joint inflammation in infectious synovitis.
TLR15 induction was first reported in chicken cecum
following Salmonella infection [16]. A later study has
reported the up-regulation of TLR15 expression after
stimulation of cells with live and heat-killed Gram
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from chickens, but not with equine specific pathogen
Rhodococcus equi, therefore suggesting that TLR15
may respond specifically to avian pathogens [18]. Intri-
guingly, a recent study showed the ability of a yeast lys-
ate to activate TLR15-dependent NF-kB pathways in
HEK293 cells or stimulate IL-1b mRNA upregulation
in chicken macrophages, which was abrogated by heat
inactivation or pre-exposure of the lysate to PMSF
[11]. Moreover, various TLR agonists have also been
evaluated, including PAM3CSK and FSL-1 [18,21,22].
Interestingly, studies by Nerren et al. [18] and Ciraci
et al. [21] showed an increase in TLR15 expression fol-
lowing stimulation with PAM3CSK. It has been reported
previously that not only the acylation of lipopeptides,
but also the peptide backbone structure is important in
recognition of lipopeptides by TLR2 in mammals [35,36].
Our study differs from others in the use of avian specific
Mycoplasma derived lipopeptide sequence to stimulate
the expression of an avian specific receptor.
In conclusion, this is the first study to report the in-
duction of TLR15 expression and activation of TLR15-
mediated immune responses after stimulation with a
diacylated lipopeptide derived from the avian pathogen
Mycoplasma synoviae. These findings demonstrate
MDLP as a possible ligand for TLR15. However, they do
not exclude other possible ligands for TLR15. Mamma-
lian TLR2 has a broad range of ligand specificities, and
is capable of recognizing a broad repertoire of PAMPs,
including several associated with Gram-positive bacteria,
mycobacteria, protozoan parasites, yeast, as well as mi-
crobial lipoproteins, glycoproteins, glycolipids and non-
enteric LPS [9]. TLR2 has been reported to recognize
these ligands alone or in cooperation with other TLR2
family members – TLR1, TLR6 and TLR10. Further
studies are needed to determine, whether TLR15 acts as
homodimer or as heterodimer with other chTLRs in
response to various ligands.
Additional file
Additional file 1: Estimation of siRNA transfection and knock-down
efficiency in HD11 cells. A) Transfection of cells with TYE 563™ as
observed under fluorescent microscope. HD11 cells were transfected with
150 nM TYE 563™ oligo and its expression was observed under
flourescent microscope. Transfected cells are shown in red. B) Knock
down efficiency in HD11 cells transfected with HPRT-1 siRNA as
measured by RT-qPCR. HD11 cells were transfected with 150 nM negative
control (NC siRNA) or siRNA specific for HPRT-1 (HPRT-1 siRNA) for 24 h
and mRNA expression of HPRT-1 gene was measured by RT-qPCR. Bars
show mean ± S.E. (n = 3); ***, p < 0.001.
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